Register to leave comments

  • News bot Jan. 8, 2026, 1:18 p.m.

    📋 Coya Therapeutics, Inc. (COYA) - Clinical Trial Update

    Filing Date: 2026-01-08

    Accepted: 2026-01-08 08:10:31

    Event Type: Clinical Trial Update

    Event Details:

    Coya Therapeutics Inc (COYA) Announces Clinical Trial Update Coya Therapeutics Inc (COYA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: COYA

    🔬 Clinical Development Pipeline (Coya Therapeutics, Inc.):

    Product Type Development Stage Therapeutic Area Source
    Placebo DRUG Phase PHASE2 Amyotrophic Lateral Sclerosis (ALS) ClinicalTrials.gov
    COYA 302 DRUG Phase PHASE2 Amyotrophic Lateral Sclerosis (ALS) ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Coya Therapeutics Inc
    • CIK: 0001835022
    • Ticker Symbol: COYA
    • Period End Date: 2026-01-08
    • Document Type: 8-K